Navigation Links
FDA Approves 1st in New Class of Type 2 Diabetes Drugs
Date:3/29/2013

FRIDAY, March 29 (HealthDay News) -- The first in a new class of type 2 diabetes drugs was approved Friday by the U.S. Food and Drug Administration.

Invokana (canaglifozin) tablets are to be taken, in tandem with a healthy diet and exercise, to improve blood sugar control in adults with type 2 diabetes.

Invokana belongs to a class of drugs called sodium-glucose co-transporter 2 (SGLT2) inhibitors. It works by blocking the reabsorption of glucose (sugar) by the kidney and increasing glucose excretions in urine, the FDA said in a news release.

"We continue to advance innovation with the approval of new drug classes that provide additional treatment options for chronic conditions that impact public health," Dr. Mary Parks, director of the division of metabolism and endocrinology products in the FDA's Center for Drug Evaluation and Research, said in the news release.

About 24 million Americans have type 2 diabetes, and it accounts for more than 90 percent of diabetes cases diagnosed in the United States, the FDA said. If blood sugar levels are not carefully controlled, there is an increased risk for serious complications, including heart disease, blindness, and nerve and kidney damage, the agency added.

The FDA approval is based on the findings of nine clinical trials involving more than 10,000 patients. Patients who took the drug showed improvement in hemoglobin A1c levels (a measure of blood sugar control) and fasting blood sugar levels.

Invokana should not be used by people with type 1 diabetes or people with type 2 diabetes who have increased ketones in their blood or urine (diabetic ketoacidosis), severe kidney disease, kidney failure or who are on dialysis, the FDA said.

The agency told drug maker Janssen Pharmaceuticals that it must conduct five post-approval studies of the drug to determine the risk of problems such as heart disease, cancer, pancreatitis, liver abnormalities and pregnancy
'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. FDA Approves Generic Versions of Plavix
2. FDA Approves Combo Shot for Meningitis, Hib in Kids
3. FDA Approves SonixGPS Needle Guidance Technology for Vascular Access Procedures
4. FDA Approves First New Weight-Loss Drug in More Than a Decade
5. FDA Approves 1st Pill to Help Prevent HIV Infection
6. FDA Approves 2nd New Weight-Loss Drug
7. FDA Approves Flu Vaccine for Coming Season
8. FDA Approves New Once-a-Day HIV Pill
9. FDA Approves New Type of Flu Vaccine
10. Environmental Protection Agency Approves MOMS by OdorXit as a Disinfectant
11. FDA Approves 1st Skin Patch to Combat Migraines
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FDA Approves 1st in New Class of Type 2 Diabetes Drugs
(Date:7/31/2014)... HealthDay Reporter WEDNESDAY, July ... boy" disease can often be cured with a stem cell ... critical, a new study finds. Severe combined immunodeficiency (SCID), ... group of rare genetic disorders that all but eliminate the ... infections. The term "bubble boy" became popular after a ...
(Date:7/31/2014)... 31, 2014 Recently, Agebc.com, a popular online ... revealed its new selection of trendy mother of the ... offered at promotional prices now, up to 68% off. , ... adding the new range of mother of the bride dresses. ... international clients. So far, our online shop has received thousands ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 A ... Heart Specialists is helping patients who have an ... is used for ablation procedures for patients such ... electrophysiologists at Baptist Heart Specialists were the ... new catheter this past spring, according to Biosense ...
(Date:7/31/2014)... 2014 Bedros Keuilian’s Fit Body Boot Camp ... other countries. At his annual Fitness Business Summits, some of ... their marketing strategies. But in his latest blog post, he ... marketing a personal training business is to create free ... personal trainer has a certain area that they really feel ...
(Date:7/31/2014)... Lauderdale, FL. (PRWEB) July 31, 2014 ... – USARAD Holdings Inc. a leading US Joint ... offers the most innovative and technologically advanced consumer ... SecondOpinions.com®. The teleradiology leader is providing valued members ... platform enhancing the extraordinary services already offered by ...
Breaking Medicine News(10 mins):Health News:Early Stem Cell Transplant Vital in 'Bubble Boy' Disease 2Health News:Early Stem Cell Transplant Vital in 'Bubble Boy' Disease 3Health News:Mother of the Bride Dresses Now Available With Great Discounts at Agebc.com 2Health News:New Catheter Improves Outcomes for Abnormal Heart Beat 2Health News:New Catheter Improves Outcomes for Abnormal Heart Beat 3Health News:Bedros Keuilian’s New Post Explains the Value of Fitness Information Products in Marketing a Personal Training Business 2Health News:Bedros Keuilian’s New Post Explains the Value of Fitness Information Products in Marketing a Personal Training Business 3Health News:SECONDOPINIONS.COM® Introduces Innovative Cloud-Based Medical Imaging Exchange Service for Easy Upload, Access and Sharing Anytime/Anywhere 2Health News:SECONDOPINIONS.COM® Introduces Innovative Cloud-Based Medical Imaging Exchange Service for Easy Upload, Access and Sharing Anytime/Anywhere 3
... March 3 Shopko has some groundbreaking,news for Council Bluffs. ... as well as a fifth store to the suburban Omaha ... This month, Shopko will open the first new store ... a departure from the look and layout of,current Shopko stores. ...
... Frances Barras of Nederland,Texas, along with her husband ... manufacturers because she has developed mesothelioma from,washing and ... They are represented by Dallas-based Baron & Budd, ... a refinery worker at the,Beaumont DuPont facility between ...
... attack patients have a higher risk for sudden death in ... by researchers from Washington University School of Medicine in St. ... , "There,s a two- to four-fold increase in a person,s ... happen to be depressed," says Robert. M. Carney, Ph.D., lead ...
... Park Dental, a Twin Cities area,group dental practice ... Dental,community for 40-years, announced today that it has ... practice from its Boston, Massachusetts-based,administrative services provider, American ... result of the settlement of a lawsuit in ...
... Indevus,Pharmaceuticals, Inc. (Nasdaq: IDEV ) announced today that ... Officer and Chairman of,the Board of Directors later this year ... said, "After 15 years at the helm of the company ... right for me to retire from this marvelous,company. Over the ...
... --- Testosterone appears to protect people against eating disorders, ... just social influences -- are linked to anorexia and ... University. , An ongoing, six-year study of 538 sets ... in the womb with male twins have lower risk ...
Cached Medicine News:Health News:Shopko Announces New Prototype Store in Council Bluffs 2Health News:Woman Sues DuPont and Asbestos Manufacturers After Developing Mesothelioma From Exposure to Asbestos in Husband's Work Clothes 2Health News:Clinical depression raises risk of death for heart attack patients years after attack 2Health News:Clinical depression raises risk of death for heart attack patients years after attack 3Health News:Park Dental Announces Separation From Its Administrative Service Provider 2Health News:Park Dental Announces Separation From Its Administrative Service Provider 3Health News:Indevus Pharmaceuticals Announces Retirement Plans For Its CEO and Chairman 2Health News:Indevus Pharmaceuticals Announces Retirement Plans For Its CEO and Chairman 3Health News:MSU research indicates testosterone could guard against eating disorders 2
(Date:7/31/2014)... July 31, 2014 Auxilium Pharmaceuticals, ... specialty biopharmaceutical company, today announced that the Company ... from its partner Asahi Kasei Pharma Corporation (Asahi ... successful submission of a regulatory application to the ... XIAFLEX ® (collagenase clostridium histolyticum) for the ...
(Date:7/30/2014)...  There is still time to share your ... Annual Institute for Supply Management ® – ... Management is open for submissions.  The annual competition ... of supply management by recognizing supply management organizations ... practices.  Entries are due August 22, 2014. ...
(Date:7/30/2014)... CryoLife, Inc. (NYSE: CRY), a leading medical ... vascular surgery, announced today that its Board of Directors ... quarter 2014 of $0.03 per share of common stock ... will be paid on September 19, 2014 to all ... The ex-dividend date for the quarterly dividend is September ...
Breaking Medicine Technology:Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 2Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 3Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 4Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 5Institute for Supply Management, Michigan State University to recognize companies with excellent supply management practices 2CryoLife Announces Quarterly Cash Dividend for the Third Quarter 2014 2CryoLife Announces Quarterly Cash Dividend for the Third Quarter 2014 3
... II data show RAD001 significantly increased efficacy of, letrozole tablets in women with newly diagnosed hormone-positive ... cancer, ... ... breast cancer by ...
... Presented at ASCO Annual Meeting -, ... 1 /PRNewswire-FirstCall/,-- Poniard Pharmaceuticals, Inc. (Nasdaq: ... today announced safety and efficacy results,from a ... picoplatin and,liposomal doxorubicin in patients with advanced ...
Cached Medicine Technology:Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 2Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 3Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 4Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 5Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 6Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 7Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 8Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 9Poniard Announces Positive Efficacy and Safety Data From Phase 1 Trial of Picoplatin in Multiple Tumor Types Including Ovarian Cancer 2Poniard Announces Positive Efficacy and Safety Data From Phase 1 Trial of Picoplatin in Multiple Tumor Types Including Ovarian Cancer 3Poniard Announces Positive Efficacy and Safety Data From Phase 1 Trial of Picoplatin in Multiple Tumor Types Including Ovarian Cancer 4Poniard Announces Positive Efficacy and Safety Data From Phase 1 Trial of Picoplatin in Multiple Tumor Types Including Ovarian Cancer 5
... Shaker provides the exact agitation needed ... very slow to fast speed and ... a gentle wave motion that lifts ... membranes to achieve faster, more uniform ...
Conversion Kits For Modular Incubator Chamber...
Conversion Kits For Modular Incubator Chamber...
Inquire...
Medicine Products: